public offering

搜索文档
Super League Enterprise, Inc. Announces Launch of Proposed Public Offering
Globenewswire· 2025-05-09 08:05
文章核心观点 公司宣布启动公开发行证券,所得净收益用于一般公司和营运资金需求及偿还部分债务,发行受市场条件影响 [1][2] 分组1:公司业务介绍 - 公司通过可玩媒体重新定义品牌与消费者的连接方式,为全球品牌提供可在手机游戏和大型沉浸式游戏平台中体验的广告、内容等,以独特技术和资源助力品牌脱颖而出 [5] 分组2:证券发行情况 - 公司启动公开发行证券 [1] - 发行所得净收益用于一般公司和营运资金需求及偿还部分债务 [2] - 发行受市场条件影响,能否完成、实际规模和条款均不确定 [2] - Aegis Capital Corp. 担任此次发行的独家簿记管理人,发行依据此前已生效的S - 3表格架上注册声明进行 [3] - 最终招股说明书补充文件和随附招股说明书将提交美国证券交易委员会,可在其网站获取,也可联系Aegis Capital Corp. 获取 [3]
Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering
Globenewswire· 2025-05-09 05:00
Hopewell, New Jersey, May 08, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally administered bee venom-based toxin which potentially exhibits diverse therapeutic effects, today announced the pricing of its initial public offering of 3,375,000 shares of common stock at a price of $4.00 per share. The gross proceeds to Apimeds from the offering, b ...
Dune Acquisition Corporation II Announces Closing of $143,750,000 Initial Public Offering
Globenewswire· 2025-05-09 04:05
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Dune Acquisition Corporation II (the “Company”) announced today the closing of its initial public offering of 14,375,000 units, including the exercise in full of the underwriters’ over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $143,750,000. The units are listed on the Nasdaq Global Market (the “Nasdaq”) and commenced trading under the ticker symbol “IPODU” on May 7, 2025. Each unit consists of one Class A ordinary ...
Exagen Inc. Prices Public Offering of Common Stock
GlobeNewswire News Room· 2025-05-08 20:30
CARLSBAD, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced the pricing of its previously announced underwritten public offering of 3,350,000 shares of its common stock at a public offering price of $5.25 per share. All of the shares in the offering will be sold by Exagen, with gross proceeds to Exagen expected to be $17,587,500 before deducting underwriting discounts and commissions and offering expenses. Exagen has grant ...
重磅!证监会发布《行动方案》,公募基金行业全面升级在即
环球网· 2025-05-08 10:05
【环球网财经综合报道】2025年5月7日,中国证监会发布《推动公募基金高质量发展行动方案》(简称《行动方案》),是为通过 全面深化改革,强化公募基金行业与投资者的利益绑定,增强公募基金投资行为的稳定性,提升公募基金服务投资者的能力,发展 壮大权益类公募基金,进而更好发挥行业功能。 近年来,行业主动管理权益类基金业绩波动较大,部分产品频繁追逐热点,甚至出现风格漂移等现象,《行动方案》就是要强化业 绩比较基准的约束作用,解决这一问题。 "对主动管理权益类基金,推行与基金业绩表现挂钩的浮动管理费率收取模式"是《行动 方案》的要点之一。 根据《行动方案》,对于符合一定持有期要求的投资者,根据其持有期间产品业绩表现适用差异化的管理费率。业绩明显低于比较 基准的,须少收管理费,有力扭转基金公司"旱涝保收"的现象。 据悉,对主动管理权益类基金大力推行浮动管理费率,是本次公募基金改革的一个积极探索,为确保改革符合市场情况,证监会将 稳慎推进具体落地工作。 薪酬管理方面,《行动方案》提出系统完善基金公司考核评价制度,强化基金公司、高管、基金经理与投资者的利益绑定,督促行 业机构牢固树立以投资者最佳利益为核心的经营理念。 《行动 ...
WF Holding Limited Announces Underwriters’ Exercise of Over-Allotment Option
Globenewswire· 2025-05-08 04:15
文章核心观点 马来西亚玻璃纤维增强塑料产品制造商WF Holding Limited的承销商部分行使超额配售权,额外购买240,000股普通股,使公开发行总收益增加 [1][2] 公司基本信息 - 公司为马来西亚的玻璃纤维增强塑料(FRP)产品制造商,获ISO 9001:2015认证,有超30年历史,提供相关服务 [5] - 公司股票于2025年3月27日在纳斯达克资本市场开始交易,代码为“WFF” [2] 超额配售情况 - 承销商部分行使超额配售权,以每股4.00美元价格额外购买240,000股普通股,额外收益960,000美元 [1] - 行使超额配售权后,公开发行普通股总数增至2,240,000股,总收益增至约896万美元,期权交割日期为2025年5月7日 [2] 发行相关方 - Dominari Securities LLC担任主承销商,Revere Securities LLC担任副承销商 [2] - Bevilacqua PLLC担任公司美国法律顾问,The Crone Law Group, P.C.担任承销商美国法律顾问 [2] 注册声明与招股书 - 与发行相关的F - 1表格注册声明于2025年3月26日获美国证券交易委员会(SEC)生效,发行通过招股书和免费撰写招股书进行 [3] - 可从Dominari Securities LLC和Revere Securities LLC获取最终招股书副本,也可在SEC网站免费获取 [3]
Theriva Biologics Announces Pricing of $7.5 Million Public Offering
Globenewswire· 2025-05-07 21:17
文章核心观点 Theriva Biologics宣布公开发行股票及认股权证的定价,预计获约750万美元总收益,用于营运资金和公司一般用途,交易预计于2025年5月8日左右完成 [1][2] 发行情况 - 公司宣布“合理最大努力”公开发行,可购买和出售最多6818180股普通股或预融资认股权证,以及购买最多6818180股普通股的认股权证,组合发行价为每股及附带认股权证1.10美元 [1] - 公司预计在扣除配售代理费用和其他发行费用前,假设认股权证未行使,将获得约750万美元总收益 [1] - 认股权证行使价为每股1.10美元,可立即行使,自发行日期起五年到期 [1] 交易时间 - 发行交易预计于2025年5月8日左右完成,需满足惯常成交条件 [2] 资金用途 - 公司打算将此次发行的净收益主要用于营运资金和公司一般用途,包括研发和扩大生产规模 [2] - 公司也可能用部分净收益投资或收购其他产品、业务或技术,但目前无相关承诺或协议 [2] 配售代理 - A.G.P./Alliance Global Partners担任此次发行的独家配售代理 [3] 发行依据 - 上述证券根据2024年12月10日提交并修订的S - 1表格注册声明发行,该声明于2025年5月7日获美国证券交易委员会生效 [4] - 发行仅通过构成有效注册声明一部分的招股说明书进行,初步招股说明书已提交给美国证券交易委员会 [4] 公司简介 - Theriva Biologics是多元化临床阶段公司,开发治疗癌症及相关未满足医疗需求疾病的疗法 [1][6] - 公司子公司Theriva Biologics, S.L.开发了新的溶瘤腺病毒平台,用于静脉、玻璃体内和抗肿瘤递送 [6] - 公司主要临床阶段候选药物包括VCN - 01、SYN - 004和SYN - 020 [6] 投资者关系 - 投资者关系联系人为Kevin Gardner,来自LifeSci Advisors, LLC,邮箱kgardner@lifesciadvisors.com,电话617 - 283 - 2856 [9]
Palatin Technologies Announces Pricing of up to $23 Million Public Offering
Prnewswire· 2025-05-07 20:00
$11.5 Million Upfront with up to an Additional $11.5 Million Upon the Cash Exercise of the Milestone Related Warrants CRANBURY, N.J., May 7, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) ("Palatin" or the "Company"), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced the pricing of its public offering with participation from new and existing healthcare focused institutional ...
LyondellBasell prices public offering of guaranteed notes
GlobeNewswire News Room· 2025-05-07 05:00
Houston, May 06, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB) announced today that LYB International Finance III, LLC, its wholly-owned subsidiary, priced a public offering (the “Offering”) of $500,000,000 aggregate principal amount of 6.150% Guaranteed Notes due 2035 (the “Notes”). The Notes will be fully and unconditionally guaranteed by LyondellBasell. The Offering is expected to close on May 15, 2025, subject to the satisfaction of customary closing conditions. The net proceeds of the Offering ar ...
Dune Acquisition Corporation II Announces Pricing of $125 Million Initial Public Offering
Globenewswire· 2025-05-07 04:30
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Dune Acquisition Corporation II (the “Company”) announced today the pricing of its initial public offering of 12,500,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Global Market (the “Nasdaq”) and trade under the ticker symbol “IPODU” beginning on May 7, 2025. Each unit consists of one Class A ordinary share and three-quarters of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a ...